


FLYPHARMA Revenue
Biotechnology Research • • 1-10 Employees
FLYPHARMA revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at FLYPHARMA
Constant Tedder
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Keywords | Therapeutics, Biologics, Biomanufacturing, Bioconversion |
| Founded | 2025 |
| Employees | 1-10 |
About FLYPHARMA
FlyPharma is a biomanufacturing company pioneering the next generation of biologics through advanced insect bioconversion technologies. Our mission is to make life-saving and life-enhancing biologics radically more affordable and accessible — not just for human health, but also for animal health, where demand for scalable solutions is rapidly accelerating. Traditional biologics manufacturing is expensive, centralised, and limited to a handful of facilities worldwide. FlyPharma is changing this by engineering genetically enhanced Black Soldier Fly (BSF) strains to act as natural bioreactors, producing high-value proteins such as monoclonal antibodies (mAbs) at a fraction of conventional costs. By integrating modular production systems with automation, robotics, and AI-driven controls, we are building a platform that can be rapidly deployed, scaled, and adapted to diverse global markets. Our initial focus is on the animal health sector, where rising protein demand, antibiotic resistance, and sustainability pressures create an urgent need for breakthrough solutions. FlyPharma’s mAb-enriched products offer new pathways to improve livestock health and performance while reducing reliance on antibiotics — a transformative step for both productivity and global food security. From poultry and swine to aquaculture, our technology opens doors to multi-billion-dollar markets. At the same time, our vision extends into human health. By proving our platform in animal applications first, we are building the foundation for low-cost biologics that could one day reshape access to treatments for millions of people worldwide. With active pilot projects, global industry partnerships, and a strong innovation pipeline, FlyPharma is positioned at the intersection of biotechnology, sustainability, and industrial scale-up. We are not just lowering costs — we are redefining what’s possible in biomanufacturing. Upcycling waste. Transforming food. Democratizing biologics.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
FLYPHARMA has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
FLYPHARMA has never raised funding before.
Frequently asked questions
4.8
40,000 users



